Millions of federal tax dollars have been spent as part of an effort to create a “one-stop fetal tissue shop” at the University of Pittsburgh, according to U.S. Department of Health and Human Services (HHS) documents revealed Aug. 3.
Nearly $3 million in federal funds went to the school beginning in 2015, according to more than 250 pages of documents obtained by Judicial Watch through a Freedom of Information Act (FOIA) lawsuit against HHS.
The lawsuit was filed after HHS failed to respond to the conservative nonprofit’s April 28 FOIA request for copies of grant applications for the university’s “tissue hub and collection site.” Judicial Watch submitted its FOIA on behalf of the Center for Medical Progress.
Judicial Watch said in a statement announcing receipt of the documents that:
- “The aims of the project listed in the original 2015 proposal were to ‘develop a pipeline to the acquisition, quality control and distribution of human genitourinary [urinary and genital organs and functions] samples obtained throughout development (6-42 weeks gestation) … [and] generate an ongoing resource to distribute fresh developmental human genitourinary samples from various stages (6-42 weeks) to the GenitoUrinary Development Molecular Anatomy Project (GUDMAN) Atlas projects.’
- “In the proposal, Pitt notes that is has been ‘collecting fetal tissue for over 10 years … include[ing] liver, heart, gonads, legs, brain, genitourinary tissues including kidneys, ureters and bladders.’
- “Pitt noted in 2015 that ‘we have disbursed over 300 fresh samples collected from 77 cases. The collections can be significantly ramped up as material could have been accrued from as many as 725 cases last year.’
- “The Health Sciences Tissue Bank at Pitt is ‘embedded within the Department of Pathology … thus providing rapid access to very high-quality tissue and biological specimens.’”
In addition, the documents indicate that school officials boast of having “a lab boasting a ‘ButcherBoy band saw for sectioning bone’ and a ‘frozen section has digital video feed to and from operating rooms. This allows for instantaneous discussions with the surgeons [as] immediate show and tell for them.”
Judicial Watch also pointed out that the school’s funding proposal to the federal government included a racial target for the human body parts to be harvested from what it called aborted “subjects.”
Under the target, school officials told HHS they planned on half of their subjects to be unborn aborted babies from minority mothers because the city of Pittsburgh is a diverse populace. Judicial Watch noted that U.S. Census Bureau data indicates that Pittsburgh is almost 70 percent Caucasian.
The funding proposal included among the documents also boasted of the school’s close relationship with laboratories at the Children’s Hospital of Pittsburgh.
“These documents show taxpayer money is being used to turn the University of Pittsburgh into a one-stop human fetal tissue shop—from procuring the tissue from elective abortions, ‘subdividing’ the human remains, to distributing and shipping the harvested tissue,” Judicial Watch President Tom Fitton said in the statement announcing receipt of the documents.
Release of the University of Pittsburgh documents comes only a few months after Secretary of Health and Human Services Xavier Becerra ended regulations promulgated under former President Donald Trump that severely limited research using fetal tissue.
A University of Pittsburgh spokesperson said, “This grant-supported research is to find new therapies for diseases of the kidneys, bladder, and urinary systems, which are a leading cause of organ failure. By providing a central hub for researchers across the country, this program allowed scientists across the country to access tissue necessary to tackle this growing public health concern.
“Researchers have no part in any decisions as to the timing, method, or procedures used to terminate the pregnancy. All tissue was obtained in compliance with the Pennsylvania Abortion Control Act, as noted in the grant.”
As previously reported by The Epoch Times, the National Institutes of Health (NIH) said in April that HHS would end both a ban on research funded by the NIH using fetal tissue procured from elective abortions and regulations requiring prior ethical review on such studies.
“NIH reminds the community of expectations to obtain informed consent from the donor for any NIH-funded research using human fetal tissue, and of continued obligations to conduct such research only in accord with any applicable federal, state, or local laws and regulations,” the notice reads.
Becerra also “determined there are no new ethical issues that require special review,” NIH said in the statement.
HHS didn’t immediately respond to a request by The Epoch Times for comment.
Pro-life groups are actively opposed to the use of fetal tissue obtained from aborted babies. Planned Parenthood, the nation’s largest provider of abortion services, has been implicated in commercial sales of fetal tissue.
Fox News recently reported that three invoices unsealed in a lawsuit filed by Planned Parenthood against independent journalist David Daleiden, whose controversial undercover videos in 2015 sparked widespread calls for official investigations, showed that the abortion provider charged a total of nearly $25,000 for “products of procreation,” or POCs.
Read Original Article on TheEpochTimes.com
This is sick, twisted and evil.
— Donald Trump Jr. (@DonaldJTrumpJr) August 5, 2021
I don’t care if you’re pro-choice or pro-life, if you’re okay with torturing an unborn baby like this, then you need to seek help immediately.
Everyone involved should be behind bars. https://t.co/V8qlqa3eos
Judicial Watch: New HHS Documents Reveal Millions in Federal Funding for University of Pittsburgh Human Fetal Organ Harvesting Project Including Viable and Full-Term Babies
(Washington, DC) Judicial Watch and The Center for Medical Progress (CMP) announced today that they received 252 pages of new documents from the US Department of Health and Human Services that reveal nearly $3 million in federal funds were spent on the University of Pittsburgh’s quest to become a “Tissue Hub” for human fetal tissue ranging from 6 to 42 weeks gestation.
These documents were obtained as part of the Freedom of Information Act (FOIA) lawsuit in which Judicial Watch represents CMP and is suing HHS after it failed to respond to an April 28, 2020, FOIA request seeking among other things, the grant applications for a University of Pittsburgh “tissue hub and collection site.” (Center for Medical Progress v. U.S. Department of Health and Human Services (No. 1:21-cv-00642)).
The documents reveal the following:
- The aims of the project listed in the original 2015 proposal were to “develop a pipeline to the acquisition, quality control and distribution of human genitourinary [urinary and genital organs and functions] samples obtained throughout development (6-42 weeks gestation). … [and] generate an ongoing resource to distribute fresh developmental human genitourinary samples from various stages (6-42 weeks) to the GUDMAP [GenitoUrinary Development Molecular Anatomy Project] Atlas projects.”
- In the proposal, Pitt notes that is has been “collecting fetal tissue for over 10 years … include[ing] liver, heart, gonads, legs, brain, genitourinary tissues including kidneys, ureters and bladders.”
- Pitt noted in 2015 “we have disbursed over 300 fresh samples collected from 77 cases. The collections can be significantly ramped up as material could have been accrued from as many as 725 cases last year.”
- The Health Sciences Tissue Bank at Pitt is “embedded within the Department of Pathology … thus providing rapid access to very high quality tissue and biological specimens.”
- Pitt boasts it has a number of internal connections as well as a “strong working relationship with UPMC [University of Pittsburgh Medical Center] and the Department of Pathology” as well as three “laboratories in the flagship UPMC hospitals.” This includes a lab boasting a “ButcherBoy band saw for sectioning bone,” and a “frozen section room has digital video feed to and from the operating rooms. This also allows for instantaneous discussions with the surgeons as well [as] immediate ‘show and tell’ for them.” The proposal ironically also boasts about the laboratories at the “Children’s Hospital of Pittsburgh.”
- Later in the proposal, Pitt states that it records the “warm ischemic time on our samples and take steps to keep it at a minimum to ensure the highest quality biological specimens.” [The “warm ischemic time” refers to the amount of time an organ remains at body temperature after blood supply has been cut off. Warm ischemic time differs from cold ischemic time which refers to amount of time the organ is chilled. Pitt’s statement suggests the time between the abortion and collection is minimal.]
- The Pitt scientists note that, “All fetal tissue is collected through a collaborative process including Family Planning, Obstetrics and Pathology.” And that, “the numbers of consents and collections has been steadily increasing… and we are in an excellent position to expand our services to include the needs of the GUDMAP Atlas projects.”
- Pitt anticipated “being able to harvest and distribute quality tissue and cells … [and] do not anticipate any major problems related to the acquisition and distribution of the tissues.”
- Pitt’s target goal “is to have available a minimum of 5 cases (tissues and if possible other biologicals) per week of gestational age for ages 6-42 weeks.”
- Pitt’s proposal also included a racial target for harvesting of human fetal parts. Of its planned aborted “subjects” Pitt desired 50% to be minority fetuses. The proposal suggests that the “subjects” be diverse because Pittsburgh is diverse, the U.S. Census Bureau shows the city of Pittsburgh is close to 70% white.
- Pitt’s proposal requested more than $3.2 million over a five-year period. The documents show NIH has funded at least $2.7 million so far for Pitt’s human fetal tissue harvesting and hub.
In March 2021, a federal court ordered HHS to release additional information about its purchases of organs harvested from aborted human fetuses. The court also found “there is reason to question” whether the transactions violate federal law barring the sale of fetal organs.
In May 2021, Judicial Watch announced it had uncovered records from the FDA showing the agency spent tens of thousands of taxpayer dollars to buy human fetal tissue from California-based Advanced Bioscience Resources (ABR). The tissue was used in creating “humanized mice” to test “biologic drug products.” The records show the agency ordered shipments to be “fresh; shipped on wet ice.”
In June 2020, Judicial Watch released records showing the FDA between 2012 and 2018 entered into eight contracts worth $96,370 with Advanced Bioscience Resources (ABR) to acquire “fresh and never frozen” tissue from 1st and 2nd trimester aborted fetuses for use in creating humanized mice for ongoing research. In February 2020, Judicial Watch made public additional humanized mice records.
“These documents show taxpayer money is being used to turn the University of Pittsburgh is a one-stop human fetal tissue shop – from procuring the tissue from elective abortions, ‘subdividing’ the human remains, to distributing and shipping the harvested tissue,” stated Judicial Watch President Tom Fitton.
The Center for Medical Progress’ press release is available here.
